In TCGA NSCLC cohorts, a total of 35 pathway gene sets were found to be significantly suppressed or activated in tumors with KMT2C/BCOR/KDM5C mutations (Table S3). The gene discussed is KDM5C; the disease is non-small cell lung carcinoma.